iifl-logo

Glenmark Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
2,136.7
(0.58%)
Feb 27, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Historical Data

02/02/2026calendar-icon
02/03/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

01-Feb-2026

2,011

2,0111,9291,94018,99474,32,54,911.689,168

02-Feb-2026

1,935.1

1,964.41,8421,920.470,9202,80,60,92,248.97,55,708

03-Feb-2026

1,995

2,006.61,947.61,954.236,9251,05,27,11,914.82,73,449

04-Feb-2026

1,954.2

1,992.11,945.91,959.334,91476,26,05,531.71,81,825

05-Feb-2026

1,955.2

1,976.31,9261,969.334,41778,21,99,2211,65,283

06-Feb-2026

1,969.3

1,969.31,9111,934.837,52094,79,12,075.32,65,078

09-Feb-2026

1,958

1,979.91,941.41,974.424,98878,61,71,3912,22,184

10-Feb-2026

2,000

2,000.11,953.41,95819,43554,93,89,150.31,34,172

11-Feb-2026

1,959.9

2,018.91,949.92,015.234,3481,09,55,47,6192,18,833

12-Feb-2026

2,020

2,0392,001.12,034.523,60368,70,70,061.51,20,535

13-Feb-2026

2,034

2,047.91,9921,997.638,2681,74,91,36,737.33,60,788

16-Feb-2026

1,997.6

2,037.41,9882,030.528,3181,29,41,51,348.63,17,117

17-Feb-2026

2,028.9

2,046.92,021.82,038.812,88241,10,39,370.794,762

18-Feb-2026

2,038

2,044.52,0092,030.218,10271,20,01,318.21,91,174

19-Feb-2026

2,028

2,0572,0052,016.722,83273,52,55,3111,48,571

20-Feb-2026

2,005

2,049.81,999.22,043.218,24762,68,54,529.31,36,497

23-Feb-2026

2,043.2

2,053.62,021.82,039.223,04159,92,15,803.21,38,395

24-Feb-2026

2,028.5

2,078.52,025.42,058.621,56076,21,99,507.31,92,682

25-Feb-2026

2,070

2,092.32,0612,08523,98894,67,39,772.62,28,631

26-Feb-2026

2,080

2,1392,0802,124.328,9201,09,22,89,1402,20,457

27-Feb-2026

2,125.6

2,159.82,116.42,136.735,0361,31,84,27,191.32,59,454

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.